1-Year Outcomes After Tricuspid Edge-to-Edge Valve Repair

Study Questions:

What are the procedural and 1-year clinical and echocardiographic outcomes of patients treated with tricuspid edge-to-edge repair?

Methods:

The investigators analyzed 249 patients with severe TR treated with edge-to-edge repair in compassionate and/or off-label use in the multicenter international TriValve (Transcatheter Tricuspid Valve Therapies) registry. Clinical and echocardiographic outcomes were prospectively collected and retrospectively analyzed.

Results:

In 249 patients (mean age 77 ± 9 years; European System for Cardiac Operative Risk Evaluation II score 6.4% [interquartile range, 3.9-13.9%]), a successful procedure with TR reduction to grade ≤2+ was achieved in 77% by placement of 2 ± 1 tricuspid clips. Concomitant treatment of severe TR and mitral regurgitation was performed in 52% of patients. At 1-year follow-up, significant and durable improvements in TR severity (TR ≤2+ in 72% of patients) and New York Heart Association functional class (≤II in 69% of patients) were observed. All-cause mortality was 20%, and the combined rate of mortality and unplanned hospitalization for heart failure was 35%. Predictors of procedural failure included effective regurgitant orifice area, tricuspid coaptation gap, tricuspid tenting area, and absence of central or anteroseptal TR jet location. Predictors of 1-year mortality were procedural failure, worsening kidney function, and absence of sinus rhythm.

Conclusions:

The authors concluded that transcatheter tricuspid edge-to-edge repair can achieve TR reduction at 1 year, resulting in significant clinical improvement.

Perspective:

This analysis from the international multicenter TriValve registry reports that transcatheter tricuspid edge-to-edge valve repair is safe and results in durable TR reduction at 1-year follow-up with 77% of patients having TR grade ≤2+ and is also associated with significant clinical improvement. Additional refinement in optimizing patient selection, imaging, device innovation, and operator experience may further improve procedural success and outcomes in this high-risk patient population. Prospective studies are indicated to assess a potential survival benefit with transcatheter tricuspid edge-to-edge valve repair, as indicated by these preliminary data.

Keywords: Cardiology Interventions, Echocardiography, Diagnostic Imaging, Geriatrics, Heart Failure, Heart Valve Diseases, Mitral Valve Insufficiency, Off-Label Use, Secondary Prevention, Tricuspid Valve Insufficiency


< Back to Listings